KURT VERNON
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology
- Where
- DUNN, NC
- NPI
- 1871559930
- Received
- $48,075 in 129 records, 2019 to 2025 ($1,934 general, $46,141 research)
- As principal investigator
- $56,500 of research payments to others in 8 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 21 | $474 |
| 2024 | General payment | 13 | $198 |
| 2023 | General payment | 45 | $663 |
| 2022 | General payment | 11 | $229 |
| 2021 | General payment | 5 | $89 |
| 2021 | Research payment | 1 | $4,250 |
| 2020 | General payment | 3 | $46 |
| 2020 | Research payment | 1 | $41,891 |
| 2019 | General payment | 29 | $231 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 2 | $46,141 |
| Food and Beverage | 127 | $1,934 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | Celltrion USA Inc. | $20 | Food and Beverage | In-kind items and services | VEGZELMA Biological, ONCOLOGY | 2025 | |
| 2025-12-16 | Phathom Pharmaceuticals, Inc. | $11 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-12-11 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-12-09 | GENZYME CORPORATION | $31 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-12-04 | Ardelyx, Inc. | $28 | Food and Beverage | In-kind items and services | IBSRELA Drug, GASTROENTEROLOGY | 2025 | |
| 2025-11-25 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-11-03 | VIVUS LLC | $13 | Food and Beverage | In-kind items and services | PANCREAZE Drug, GASTROENTEROLOGY | 2025 | |
| 2025-10-07 | GENZYME CORPORATION | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-02 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-09-02 | Phathom Pharmaceuticals, Inc. | $20 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-08-28 | GENZYME CORPORATION | $28 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-08-19 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-08-07 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2025 | |
| 2025-07-22 | GENZYME CORPORATION | $34 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-07-10 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-06-12 | GENZYME CORPORATION | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-05-29 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-05-08 | Aimmune Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2025 | |
| 2025-02-13 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2025 | |
| 2025-01-29 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-01-15 | Madrigal Pharmaceuticals | $30 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2024-11-20 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-07-24 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-07-03 | GENZYME CORPORATION | $14 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-06-17 | Endogastric Solutions, Inc | $9 | Food and Beverage | Cash or cash equivalent | ESOPHYX Device, GERD | 2024 | |
| 2024-06-17 | Endogastric Solutions, Inc | $2 | Food and Beverage | Cash or cash equivalent | ESOPHYX Device, GERD | 2024 | |
| 2024-06-12 | Ipsen Biopharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | IQIRVO Drug, Rare Disease | 2024 | |
| 2024-05-29 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-05-22 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2024 | |
| 2024-05-09 | Regeneron Healthcare Solutions, Inc. | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-04-24 | Intercept Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | OCALIVA Drug, Hepatology / Gastroenterology | 2024 | |
| 2024-04-17 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2024 | |
| 2024-02-14 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2024 | |
| 2024-02-02 | Phathom Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2023-12-07 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2023 | |
| 2023-12-06 | Celgene Corporation | $19 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-12-06 | Phathom Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2023 | |
| 2023-11-29 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-11-15 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-10-16 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-10-02 | Braintree Laboratories, Inc. | $13 | Food and Beverage | In-kind items and services | SUFLAVE Drug, GI COLON PREP | 2023 | |
| 2023-09-21 | Alexion Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2023 | |
| 2023-09-06 | Daiichi Sankyo Inc. | $15 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2023 | |
| 2023-09-05 | GENZYME CORPORATION | $24 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-08-31 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-07-26 | EVOKE PHARMA, INC. | $13 | Food and Beverage | In-kind items and services | GIMOTI Drug, Gastroenterology | 2023 | |
| 2023-07-18 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2023 | |
| 2023-07-12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | CYLTEZO Drug, CNS | 2023 | |
| 2023-07-10 | Merck Sharp & Dohme LLC | $13 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2023 | |
| 2023-06-27 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13 | Food and Beverage | In-kind items and services | TRULANCE Drug, Gastroenterology | 2023 | |
| 2023-06-21 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-06-14 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2023 | |
| 2023-06-13 | Organon Llc | $28 | Food and Beverage | In-kind items and services | RENFLEXIS Drug, INFLIXIMAB | 2023 | |
| 2023-06-07 | Regeneron Healthcare Solutions, Inc. | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-06-07 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2023 | |
| 2023-06-07 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2023 | |
| 2023-05-02 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | AMJEVITA Biological, Inflammation | 2023 | |
| 2023-04-13 | Mauna Kea Technologies, Inc. | $2 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-04-11 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-04-03 | Mauna Kea Technologies, Inc. | $2 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-03-29 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2023 | |
| 2023-03-16 | GENZYME CORPORATION | $14 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-03-16 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2023 | |
| 2023-02-28 | Mauna Kea Technologies, Inc. | $26 | Food and Beverage | Cash or cash equivalent | 2023 | ||
| 2023-02-22 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2023 | |
| 2023-02-09 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-02-08 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2023 | |
| 2023-02-01 | Celgene Corporation | $26 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2023 | |
| 2023-02-01 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2023 | |
| 2023-01-30 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2023 | |
| 2023-01-25 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2023 | |
| 2023-01-25 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2023 | |
| 2023-01-12 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2023 | |
| 2023-01-11 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-01-10 | NESTLE HEALTHCARE NUTRITION INC. | $13 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2023 | |
| 2023-01-06 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2023 | |
| 2023-01-05 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-01-03 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2022-12-07 | Gilead Sciences, Inc. | $24 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-22 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2022 | |
| 2022-11-15 | Regeneron Healthcare Solutions, Inc. | $17 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-10-26 | Mauna Kea Technologies, Inc. | $66 | Food and Beverage | Cash or cash equivalent | 2022 | ||
| 2022-10-25 | RedHill Biopharma Inc. | $16 | Food and Beverage | In-kind items and services | Talicia Drug, Antibiotic | 2022 | |
| 2022-10-05 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13 | Food and Beverage | In-kind items and services | RELISTOR Drug, Gastroenterology | 2022 | |
| 2022-09-06 | Braintree Laboratories, Inc. | $13 | Food and Beverage | In-kind items and services | SUTAB Drug, GI COLON PREP | 2022 | |
| 2022-08-24 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2022 | |
| 2022-08-22 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2022 | |
| 2022-08-10 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2022 | |
| 2022-06-01 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | TRULANCE Drug, Gastroenterology | 2022 | |
| 2021-12-08 | Mauna Kea Technologies, Inc. | $20 | Food and Beverage | Cash or cash equivalent | 2021 | ||
| 2021-11-06 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2021 | |
| 2021-09-15 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2021 | |
| 2021-08-10 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2021 | |
| 2021-05-26 | RedHill Biopharma Inc. | $24 | Food and Beverage | In-kind items and services | Talicia Drug, Antibiotic | 2021 | |
| 2021-02-03 | Celltrion, Inc. | $4,250 | Research payment | Cash or cash equivalent | CT-P13 3.8 | 2021 | |
| 2020-12-17 | Celltrion, Inc. | $41,891 | Research payment | Cash or cash equivalent | CT-P13 3.8 | 2020 | |
| 2020-03-04 | Intercept Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 2020 | |
| 2020-03-02 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-02-06 | Allergan, Inc. | $14 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2020 | |
| 2019-12-19 | Allergan, Inc. | $12 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-12-17 | Allergan, Inc. | $2 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-12-09 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | Creon Drug, Endocrinology | 2019 | |
| 2019-12-03 | Allergan, Inc. | $5 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-12-03 | Allergan, Inc. | $3 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-11-26 | Allergan, Inc. | $1 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-11-19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | APRISO Drug, GASTROENTEROLOGY | 2019 | |
| 2019-11-19 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | Entyvio Biological, Lower GI | 2019 | |
| 2019-11-19 | Allergan, Inc. | $2 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-11-18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $10 | Food and Beverage | In-kind items and services | RELISTOR Drug, GASTROENTEROLOGY | 2019 | |
| 2019-10-22 | Allergan, Inc. | $6 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-10-10 | Allergan, Inc. | $5 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-10-10 | Allergan, Inc. | $3 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-09-26 | Allergan, Inc. | $21 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-09-16 | Allergan, Inc. | $10 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-09-10 | Allergan, Inc. | $7 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-07-30 | Allergan, Inc. | $2 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-07-25 | Allergan, Inc. | $2 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-06-12 | Allergan, Inc. | $3 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-06-12 | Allergan, Inc. | $2 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-05-22 | Braintree Laboratories, Inc. | $10 | Food and Beverage | In-kind items and services | SUPREP BOWEL PREP Drug, GI COLON PREP | 2019 | |
| 2019-04-10 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-04-09 | Allergan, Inc. | $2 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 | |
| 2019-04-05 | Allergan, Inc. | $1 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-04-04 | Allergan, Inc. | $4 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-04-04 | Allergan, Inc. | $0 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-03-19 | Allergan, Inc. | $1 | Food and Beverage | In-kind items and services | ZENPEP Drug, CYSTIC FIBROSIS | 2019 | |
| 2019-02-20 | Takeda Pharmaceuticals U.S.A., Inc. | $10 | Food and Beverage | In-kind items and services | Dexilant Drug, Upper GI | 2019 | |
| 2019-02-19 | Allergan, Inc. | $31 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-07-31 | F. Hoffmann-La Roche AG | OMEGA RESEARCH NORTH CAROLINA LLC | $15,000 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participan | 2025 |
| 2025-07-10 | F. Hoffmann-La Roche AG | OMEGA RESEARCH NORTH CAROLINA LLC | $3,500 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participan | 2025 |
| 2025-07-10 | F. Hoffmann-La Roche AG | OMEGA RESEARCH NORTH CAROLINA LLC | $1,000 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participan | 2025 |
| 2025-07-10 | F. Hoffmann-La Roche AG | OMEGA RESEARCH NORTH CAROLINA LLC | $4,000 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participan | 2025 |
| 2025-07-10 | F. Hoffmann-La Roche AG | OMEGA RESEARCH NORTH CAROLINA LLC | $4,750 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participan | 2025 |
| 2025-02-11 | Genentech, Inc. | OMEGA RESEARCH NORTH CAROLINA LLC | $9,250 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants | 2025 |
| 2025-02-11 | Genentech, Inc. | OMEGA RESEARCH NORTH CAROLINA LLC | $4,000 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants | 2025 |
| 2025-02-11 | Genentech, Inc. | OMEGA RESEARCH NORTH CAROLINA LLC | $15,000 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Dunn, NC, county Harnett County, NC, state North Carolina; placed by its city name.
| Measure | Place (city or town) Dunn, NC | County Harnett County, NC | State North Carolina |
|---|---|---|---|
| Population B01003 | 8,559 | 139,150 | 10,730,404 |
| Population, 2020 census P1 | 8,446 | 133,568 | 10,439,388 |
| Median age B01002 | 43.2 | 35.6 | 39.1 |
| Under 18 B01001 | 21.1% | 25.4% | 21.8% |
| 65 and over B01001 | 22.4% | 13.7% | 17.2% |
| Households B11001 | 3,753 | 49,845 | 4,282,345 |
| Foreign born B05002 | 5.5% | 6.5% | 9.1% |
| Median household income B19013 | $46,830 | $71,287 | $72,388 |
| Median family income B19113 | $70,461 | $86,012 | $90,290 |
| Per capita income B19301 | $36,496 | $33,463 | $41,385 |
| Poverty rate B17001 | 19.7% | 13.7% | 13.0% |
| Unemployment rate B23025 | 3.2% | 4.7% | 4.7% |
| Civilian labor force B23025 | 3,761 | 59,664 | 5,336,863 |
| Mean commute (minutes) B08013 | 24.8 | 32.8 | 25.1 |
| Bachelor's degree or higher B15003 | 20.9% | 24.5% | 35.7% |
| Housing units B25001 | 4,229 | 54,902 | 4,895,668 |
| Owner-occupied B25003 | 54.0% | 71.0% | 66.6% |
| Renters B25003 | 46.0% | 29.0% | 33.4% |
| Median home value B25077 | $193,900 | $246,200 | $288,900 |
| Median gross rent B25064 | $788 | $1,112 | $1,228 |
| White, not Hispanic B03002 | 50.2% | 58.2% | 60.0% |
| Black B03002 | 32.6% | 19.8% | 20.0% |
| Hispanic or Latino B03002 | 11.5% | 15.1% | 11.3% |
| Asian B03002 | 0.6% | 0.9% | 3.3% |
| American Indian and Alaska Native B03002 | 0.7% | 0.6% | 0.8% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Dunn, NC.
Comments